{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:30:32Z","timestamp":1757313032141,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperintense Acute Reperfusion Marker (HARM) is a hyperintense subarachnoid signal on FLAIR MRI sequence caused by gadolinium contrast leakage into the subpial space. While, on FLAIR, HARM may mimic subarachnoid hemorrhage, it is differentiated from it on computed tomography (CT) and SWAN MRI sequences. Cerebral microbleeds are black, rounded spots on SWAN caused by blood-products deposition following red blood cell leakage from small cerebral vessels brain. Both microbleeds and HARM carry important prognostic implication as they are associated with blood-brain barrier disruption and an increased risk of intracerebral hemorrhage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 79-year-old man presented with aphasia and right hemiparesis due to ischemic stroke with left middle cerebral artery occlusion. Admission NIHSS score was 7, and he was successfully treated by intravenous thrombolysis and mechanical thrombectomy. On day 1, his clinical condition worsened, and he had an urgent gadolinium-enhanced MRI. There was no evidence of early recurrence, nor of hemorrhage on SWAN or on FLAIR. Left middle cerebral artery was permeable. The patient was anticoagulated for newly diagnosed atrial fibrillation, and a second MRI following a generalized tonic-clonic seizure showed multiple left hemispheric diffusion-weighted imaging (DWI) hyperintense spots and a left hemispheric sub-arachnoid hyperintensity on FLAIR, compatible with a subarachnoid hemorrhage. This diagnosis was excluded by SWAN MRI sequence and a normal cerebral CT the same day. The diagnosis of HARM was retained. At day 9, patient\u2019s condition improved, and a control MRI did not show evidence of HARM. However, numerous microbleeds were detected in the left hemisphere only (ipsilateral with HARM and stroke).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case highlights first of all the importance of differentiating HARM and subarachnoid hemorrhage, especially in an anticoagulated patient with clinical aggravation. Secondly, it is crucial to identify microbleeds and understand their pathophysiology, as they are associated with higher risk of hemorrhage and stroke recurrence in ischemic stroke patients. Finally, the mono-hemispheric appearance of microbleeds in this case suggests for the first time that, in some acute ischemic stroke patients, a relationship between HARM and cerebral microbleeds may exist.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02658-6","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:03:38Z","timestamp":1649930618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ipsilateral blooming of microbleeds after Hyperintense Acute Reperfusion Marker sign in an ischemic Stroke patient, a case report"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-6890","authenticated-orcid":false,"given":"Luigi Francesco","family":"Saccaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Bekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"De Malherbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intissar","family":"Hmida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Pico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"2658_CR1","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/STROKEAHA.119.025914","volume":"50","author":"M Luby","year":"2019","unstructured":"Luby M, Hsia AW, Nadareishvili Z, Cullison K, Pednekar N, Adil MM, et al. Frequency of blood-brain barrier disruption post-endovascular therapy and multiple Thrombectomy passes in acute ischemic Stroke patients. Stroke. 2019;50:2241\u20134.","journal-title":"Stroke"},{"key":"2658_CR2","doi-asserted-by":"crossref","unstructured":"Kidwell CS, Burgess R, Menon R, Warach S, Latour LL. Hyperacute injury marker ( HARM ) in primary hemorrhage a distinct form of CNS barrier disruption. Neurology. 2011.","DOI":"10.1212\/WNL.0b013e318236ef46"},{"key":"2658_CR3","doi-asserted-by":"crossref","unstructured":"Gupta R, Sun CJ, Rochestie D, Owada K, Khaldi A, Johnson AK, et al. Presence of the hyperintense acute reperfusion marker on MRI after mechanical thrombectomy for large vessel occlusion is associated with worse early neurological recovery. J NeuroIntervent Surg. 2016:1\u20133.","DOI":"10.1136\/neurintsurg-2016-012498"},{"key":"2658_CR4","doi-asserted-by":"publisher","first-page":"e15494","DOI":"10.1097\/MD.0000000000015494","volume":"98","author":"J Kang","year":"2019","unstructured":"Kang J, Kwon H, Jung CK, Bae HJ, Han MK, Kim BJ, et al. Usefulness of hyperintense acute reperfusion marker sign in patients with transient neurologic symptom. Medicine (Baltimore). 2019;98:e15494.","journal-title":"Medicine (Baltimore)"},{"key":"2658_CR5","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.3174\/ajnr.A0694","volume":"28","author":"JM Morris","year":"2007","unstructured":"Morris JM, Miller GM. Increased signal in the subarachnoid space on fluid-attenuated inversion recovery imaging associated with the clearance dynamics of gadolinium chelate: a potential diagnostic pitfall. AJNR Am J Neuroradiol. 2007;28:1964\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2658_CR6","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1161\/01.STR.0000144051.32131.09","volume":"35","author":"S Warach","year":"2004","unstructured":"Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004;35:2659\u201361.","journal-title":"Stroke"},{"key":"2658_CR7","doi-asserted-by":"publisher","unstructured":"Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012. https:\/\/doi.org\/10.1212\/WNL.0b013e3182697e70.","DOI":"10.1212\/WNL.0b013e3182697e70"},{"key":"2658_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/STROKEAHA.113.003792","volume":"45","author":"A-H Cho","year":"2014","unstructured":"Cho A-H, Cho Y-P, Lee DH, Kwon T-W, Kwon SU, Suh D-C, et al. Reperfusion injury on magnetic resonance imaging after carotid revascularization. Stroke. 2014;45:602\u20134.","journal-title":"Stroke"},{"key":"2658_CR9","doi-asserted-by":"crossref","unstructured":"Villringer K, Grittner U, Brunecker P, Khalil AA. DCE-MRI blood \u2013 brain barrier assessment in acute ischemic stroke. Neurology. 2016.","DOI":"10.1212\/WNL.0000000000003566"},{"key":"2658_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00330-002-1546-4","volume":"13","author":"A Bozzao","year":"2003","unstructured":"Bozzao A, Floris R, Fasoli F, Fantozzi LM, Colonnese C, Simonetti G. Cerebrospinal fluid changes after intravenous injection of gadolinium chelate: assessment by FLAIR MR imaging. Eur Radiol. 2003;13:592\u20137.","journal-title":"Eur Radiol"},{"key":"2658_CR11","doi-asserted-by":"crossref","unstructured":"Nadareishvili Z, Luby M, Leigh R, Shah J, Lynch JK, Hsia AW, et al. An MRI Hyperintense acute reperfusion marker is related to elevated peripheral monocyte count in acute ischemic Stroke. J Neuroimaging. 2017:1\u20134.","DOI":"10.1111\/jon.12462"},{"key":"2658_CR12","first-page":"1","volume":"11","author":"A F\u00f6rster","year":"2016","unstructured":"F\u00f6rster A, Wenz H, B\u00f6hme J, Al-Zghloul M, Groden C. Hyperintense acute reperfusion marker on FLAIR in posterior circulation infarction. PLoS One. 2016;11:1\u20138.","journal-title":"PLoS One"},{"key":"2658_CR13","first-page":"9829823","volume":"2016","author":"A F\u00f6rster","year":"2016","unstructured":"F\u00f6rster A, Wenz H, Groden C. Hyperintense acute reperfusion marker on FLAIR in a patient with transient ischemic attack. Case Rep Radiol. 2016;2016:9829823.","journal-title":"Case Rep Radiol."},{"key":"2658_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(19)30197-8","volume":"18","author":"D Wilson","year":"2019","unstructured":"Wilson D, Ambler G, Lee KJ, et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. Lancet Neurol. 2019;18:653\u201365.","journal-title":"Lancet Neurol"},{"key":"2658_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","volume":"49","author":"SM Greenberg","year":"2018","unstructured":"Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy evolution of the Boston criteria. Stroke. 2018;49:491\u20137.","journal-title":"Stroke"},{"key":"2658_CR16","doi-asserted-by":"publisher","first-page":"105294","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105294","volume":"29","author":"J De Prey","year":"2020","unstructured":"De Prey J, Yu C, Echevarria FD, Barreto I, Rees JH, DeJesus RO, et al. Iodinated contrast extravasation on post-revascularization computed tomography mimics magnetic resonance Hyperintense acute reperfusion marker: a case study. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2020;29:105294.","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"2658_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3348\/kjr.2015.16.4.906","volume":"16","author":"H Lee","year":"2015","unstructured":"Lee H, Kim E, Lee KM, Kim JH, Bae YJ, Choi BS, et al. Clinical implications of Sulcal enhancement on Postcontrast fluid attenuated inversion recovery images in patients with acute Stroke symptoms. Korean J Radiol. 2015;16:906\u201313.","journal-title":"Korean J Radiol"},{"key":"2658_CR18","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s00330-015-3749-5","volume":"25","author":"AC Ostwaldt","year":"2015","unstructured":"Ostwaldt AC, Rozanski M, Schaefer T, Ebinger M, Jungeh\u00fclsing GJ, Villringer K, et al. Hyperintense acute reperfusion marker is associated with higher contrast agent dosage in acute ischaemic stroke. Eur Radiol. 2015;25:3161\u20136.","journal-title":"Eur Radiol"},{"key":"2658_CR19","doi-asserted-by":"publisher","unstructured":"Choi HY, Lee KM, Kim H, Kim EJ, Choi WS. Role of Hyperintense acute reperfusion marker for classifying the Stroke etiology. Front Neurol. 2017. https:\/\/doi.org\/10.3389\/fneur.2017.00630.","DOI":"10.3389\/fneur.2017.00630"},{"key":"2658_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jns.2019.07.004","volume":"404","author":"A F\u00f6rster","year":"2019","unstructured":"F\u00f6rster A, Wenz H, B\u00f6hme J, Groden C. Gadolinium leakage in ocular structures\u00a0: a novel MRI finding in transient global amnesia. J Neurol Sci. 2019;404:63\u20135.","journal-title":"J Neurol Sci"},{"key":"2658_CR21","doi-asserted-by":"crossref","unstructured":"F\u00f6rster A, Al-Zghloul M, Wenz H, B\u00f6hme J, Groden C, Alonso A. Gadolinium leakage in ocular structures is common in lacunar infarction. Stroke. 2018:2018\u201320.","DOI":"10.1161\/STROKEAHA.118.023573"},{"key":"2658_CR22","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/STROKEAHA.109.572594","volume":"41","author":"CE Lovelock","year":"2010","unstructured":"Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41:1222\u20138.","journal-title":"Stroke"},{"key":"2658_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0238456","volume":"15","author":"T Umemura","year":"2020","unstructured":"Umemura T, Mashita S, Kawamura T. Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation. PLoS One. 2020;15:1\u201312.","journal-title":"PLoS One"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02658-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02658-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02658-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T19:19:56Z","timestamp":1650050396000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02658-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2658"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02658-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}